Methods for identifying tumors that are responsive to treatment with anti-ErbB2 antibodies

Details for Australian Patent Application No. 2010200692 (hide)

Owner Genentech, Inc. F. Hoffman-La Roche AG

Inventors Koll, Hans; Bossenmaier, Birgit; Muller, Hans-Joachim; Sliwkowski, Mark X.

Agent Griffith Hack

Pub. Number AU-A-2010200692

Parent 2003273218

Filing date 25 February 2010

Wipo publication date 18 March 2010

International Classifications

C07K 14/485 (2006.01) Peptides having more than 20 amino acids

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

11 March 2010 Complete Application Filed

18 March 2010 Application Open to Public Inspection

  Published as AU-A-2010200692

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010200693-Device for production of drip irrigation tubes

2010200691-Descendants of Hybrid Mushroom Strain J9277, Their Descendants, and Related Methods